课题基金 / 基金详情

Novel cross-protective (universal) vaccine for influenza infections

Novel cross-protective (universal) vaccine for influenza infections
针对流感感染的新型交叉保护(通用)疫苗
批准号:
256965
负责人:
Agrawal Babita
金额:
$11.66万
依托单位:
依托单位国家:
加拿大
项目类别:
Operating Grants
财政年份:
2012
资助国家:
加拿大
项目状态:
已结题
起止时间:
2012-02-01 至 2013-02-01

项目摘要

项目成果

Agrawal Babita的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Influenza viruses cause seasonal yearly epidemics affecting people of all ages, resulting in thousands of deaths and hospitalizations each year worldwide. There have been three influenza pandemics in the last century, each leading to millions of deaths w
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Investigation of novel host-based approaches for the treatment of tuberculosis
  • 批准号:
    418786
  • 项目类别:
    Operating Grants
  • 资助金额:
    $57.4万
  • 财政年份:
    2020
  • 负责人:
    Agrawal Babita
  • 依托单位:
Development of a novel universal (cross-protective) vaccine technology for influenza viruses
  • 批准号:
    402674
  • 项目类别:
    Operating Grants
  • 资助金额:
    $26.75万
  • 财政年份:
    2019
  • 负责人:
    Agrawal Babita
  • 依托单位:
New dual-mode antiviral agents for the treatment of hepatitis C virus infection
  • 批准号:
    283076
  • 项目类别:
    Operating Grants
  • 资助金额:
    $11.65万
  • 财政年份:
    2013
  • 负责人:
    Agrawal Babita
  • 依托单位:
Immune responses and regulation in hepatitis C virus infection: Implications for immunotherapy
  • 批准号:
    170384
  • 项目类别:
    Operating Grants
  • 资助金额:
    $43.89万
  • 财政年份:
    2008
  • 负责人:
    Agrawal Babita
  • 依托单位:
海外基金